SYSaliha Handan Yildiz

Saliha Handan Yildiz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saliha Handan Yildiz has a total of 30 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hepatoprotective effects of Scoparone in an experimental mouse model of liver fibrosis

    by Elçin Latife Kurtoğlu, Savaş Aslan, Safiye Göçer, Müjgan Özdemir Erdoğan, Saliha Handan Yıldız, Mustafa Solak

    Scoparone, a key ingredient isolated from Artemisia capillaris, has important therapeutic properties. In our study, it was aimed to investigate the therapeutic effects of systemic administration of Scoparone on liver fibrosis after the formation of liver fibrosis with Thioacetamide. In order to create a chronic fibrosis model, Swiss albino mice were injected intraperitoneally with Thioacetamide. Serum levels of AST and ALT were investigated in all groups, and TGF-β1, HGF and TNFAIP6 gene expressions from mRNA isolated from liver tissues were examined. According to our findings; ALT and AST levels of mouse serum samples in the fibrosis groups were significantly increased compared to the control, DMSO and Scoparone groups. It was observed that Scoparone injection in the fibrosis group decreased ALT and AST levels, but there was no statistically significant difference. While HGF gene expression was found to be significantly higher in liver mRNA samples in which Scoparone treatment was applied to the fibrous group, compared to all other groups, Scoparone injection to the fibrotic subjects caused a decrease in TGF-β1 gene expression (p<0.05). Injection of Scoparone into the liver fibrosis group caused a decrease in TNFAIP6 levels, but this decrease was not statistically significant. In conclusion; although scoparone does not completely regress fibrosis, it has been found to be beneficial and this is reflected in molecular analyzes. However, further studies are needed to determine the effect of different doses, to clarify its molecular mechanisms and targets, and to elucidate its toxicity.

  • Repression of Septin9 inhibits the oncogenic phenotype of bladder cancer

    by Nuray Varol, Nevin Belder, Serhat Cetin, Seyma Gul Durgut, Handan Yildiz, Fazli Polat, Sinan Sozen

  • Cytotoxic Effects of the Combination of Pam3CSK4 with Carfilzomib, Ixazomib, and Venetoclax in Human Multiple Myeloma Cells

    by K. Avci, M. Özdemir Erdoğan, S. H. Yildiz, F. Yavaşoğlu

    Proteasome inhibitors (PIs) are effective in the treatment of multiple myeloma (MM), which is a plasma cell malignancy. Different options for treating MM are a subject of research. Targeting toll-like receptors (TLRs) have been identified as a drug sensitization strategy in MM therapy. Combining anti-apoptotic protein inhibitors with PIs was effective in a broader range of patients. The aim of this study was to investigate the synergistic effects of the TLR1/2 ligand, anti-apoptotic protein inhibitor, and PIs. We activated TLR1/2 with Pam3CSK4 in U266 and NCI-H929 cell lines and investigated the cytotoxic effects of carfilzomib (CFZ), ixazomib (IXS), and venetoclax (VNT) using the WST-1 assay; BCL2, BCLXL, IRAK4, and TRAF6 expression using quantitative PCR; and BH3-interacting domain death agonist (Bid) expression using western blotting. IC50 values were lowest in both cell lines following treatment with CFZ + VNT and IXS + VNT in the presence of ligand. At the transcriptional level, BCL2, IRAK4, and TRAF6 expression was up- or downregulated depending on the combination. By contrast, BCLXL expression was downregulated with all combinations. At the translational level, enhanced protein expression of tBid was detected when the cells were treated with IXS + VNT in the presence of ligand compared with other combinations. IXS appeared to synergize the truncation of Bid, which crosslinks the extrinsic and intrinsic apoptotic pathways, in the presence of ligand and VNT. Our results provide a preclinical framework for evaluating the effects of PIs in combination with other agents to develop a new therapeutic strategy for MM.

  • Association of CUL4B with the pathogenesis of age-related cataract

    by Cem Karaosmanoğlu, Saliha Handan Yıldız, Müberra Akdoğan, Müjgan Özdemir Erdoğan

    Purpose Age-related cataract (ARC) is the most common cause of visual impairment and blindness in older adults. However, the role of CUL4B in the ARC remains unclear. Therefore, we investigated CUL4B expression and its effects on apoptosis. Materials and methods CUL4B expression levels were detected by a quantitative real-time polymerase chain reaction from the anterior lens capsules of patients with ARC and HLE-B3 cells treated with different concentrations of H2O2. CUL4B expression was silenced by siRNA transfection to evaluate apoptosis. CUL4B and apoptotic proteins B cell lymphoma 2 (Bcl-2), myeloid cell leukemia 1 (Mcl-1), caspase-3, cleaved caspase-3, Bax, Bak, and Bid were assessed using western blot analysis. Apoptosis was monitored using the TUNEL assay. Results CUL4B expression was downregulated in the anterior lens capsules (P < 0.0001) and H2O2-treated HLE-B3 cells (P = 0.0405). CUL4B protein levels were significantly lower in 100 µmol/L (P = 0.0012) and 200 µmol/L (P = 0.0041) H2O2-treated HLE-B3 cells than in the untreated cells. CUL4B expression was significantly knocked down at the mRNA (P = 0.0043) and protein levels (P = 0.0002) in HLE-B3 cells. Bcl-2 (P = 0.0199), Mcl-1 (P = 0.0042), and caspase-3 (P = 0.0142) were significantly downregulated, whereas cleaved caspase-3 (P = 0.0089) and Bak (P = 0.009) were significantly upregulated in the knockdown group. The TUNEL assay showed a greater induction of apoptosis. Conclusions CUL4B downregulation promotes the apoptosis of lens epithelial cells. Our study may help in understanding the role of CUL4B in ARC pathogenesis.


  • Open Access

    IMPACT OF BLOOD PARAMETERS ON BCR/ABL1 P210 TESTING IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN TURKIYE

    by Cem Karaosmanoğlu, Saliha Handan Yildiz, Müjgan Özdemi̇r Erdoğan, Filiz Yavaşoğlu, Haktan Doğuş

    Amaç: Kronik miyeloid lösemi (KML), BCR/ABL1 füzyon geninden kaynaklanan en yaygın hematolojik malignitelerden biridir. KML'li hastalar genellikle bazofili ve nötrofili içeren lökositoz gösterirler. KML'nin doğrulanması genellikle BCR/ABL1 füzyonunun saptanmasına dayanır. KML şüphesi olan hastalarda BCR/ABL1 p210 testi için periferik kan (PK) diferansiyeli ve tam kan sayımının (TKS) etkisini araştırmayı amaçlıyoruz. Metot: BCR/ABL1 p210 füzyonu için ilk kez test edilen hastaların retrospektif bir değerlendirmesini yaptık. Kliniğimiz veri tabanından 235 hastanın klinik ve laboratuvar bulgularını elde ettik. BCR/ABL1 p210 füzyonu, kantitatif Gerçek Zamanlı Polimeraz Zincir Reaksiyonu (RT-qPCR) ile tespit edilmiştir. Sürekli verilerin karşılaştırılması için t-testi veya Mann-Whitney U testleri uyguladık. Her parametre için alıcı çalışma karakteristiğini (ROC eğrileri) çizdik ve ROC eğrisi altındaki alanı (AUC) hesapladık. Bulgular: 235 hastanın 25'ine (%10.6) yeni KML tanısı kondu. KML hastalarında, diferansiyel ile önemli ölçüde artmış beyaz kan hücresi sayısı (WBC) vardı. Mutlak bazofil sayısı, 0,3 × 103/uL'lik bir kesme değerine sahip olan 0,829'luk ROC eğrisi (AUC) değerinin altındaki en yüksek alanı gösterdi. KML vakalarının %76,00'ında mutlak bazofil sayısı ≥0,3 × 103/uL iken, KML olmayan vakaların %95,24'ünde mutlak bazofil sayısı <0,3 × 103/uL idi. Sonuç: Sonuçlarımız, ≥0,3 × 103/uL mutlak bazofil sayısının BCR/ABL1 p210 test istemini iyileştirmeye ve sağlık hizmeti maliyetlerini düşürmeye yardımcı olabileceğini göstermektedir. Objective: Chronic myeloid leukemia (CML) is one of the most common hematological malignancies derived from the BCR/ABL1 fusion gene. Patients with CML generally manifest leukocytosis with basophilia and neutrophilia. The verification of CML is often based on the detection of BCR/ABL1 fusion. We aimed to investigate the impact of peripheral blood (PB) differential and complete blood count (CBC) on BCR/ABL1 p210 test ordering in patients with suspected CML. Methods: We performed a retrospective assessment of patients tested for the first time for BCR/ABL1 p210 fusion. We obtained clinical and laboratory findings of 235 patients from the database of our clinic. BCR/ABL1 p210 fusion was detected by quantitative real-time polymerase chain reaction (RT-qPCR). We implemented t-tests or Mann–Whitney U tests for the comparison of continuous data. We plotted the receiver operating characteristic (ROC curves) and calculated the area under the ROC curve (AUC) for each parameter. Results: Among 235 patients, 25 (%10.6) received a new diagnosis of CML. CML patients had significantly increased white blood cell count (WBC) with differential. Absolute basophil count showed the highest area under the ROC curve (AUC) value of 0.829, which had a cut-off value of 0.3 × 103/ µL. 76.00% of CML cases had an absolute basophil count of ≥0.3 × 103/µL, while 95.24% of the non-CML cases had an absolute basophil count of <0.3 × 103/µL. Conclusions: Our results indicate that an absolute basophil count of ≥0.3 × 103/µL can help improve BCR/ABL1 p210 test ordering and reduce healthcare costs.

  • Open Access

    KROMOZOM POLİMORFİZMLERİ İLE İNFERTİLİTE ARASINDAKİ İLİŞKİNİN ANALİZİ

    by Saliha Handan Yildiz, Yakup Melik Şener, Nermin Akçali, Müjgan Özdemi̇r Erdoğan, Mustafa Yildiz

    AMAÇ: İnfertilite tanısı almış ve karyotip analizi yapılmış 391 vaka (178 kadın, 213 erkek) grubu ve 40 çiftten oluşan kontrol grubunun kromozomal polimorfizmler açısından karşılaştırılması amaçlandı. GEREÇ VE YÖNTEM: Vaka grubunun kromozom polimorfizmleri, arşivdeki dosyalar ve preparatlar kullanılarak retrospektif değerlendirildi. Kontrol grubuna ait kan örneklerinden kapalı lenfosit kültürü yapılarak karyotip analizi yapıldı. BULGULAR: Toplam satellit polimorfizmleri (13 ps+,14 ps+, 15 ps+, 21 ps+ ve 22 ps+) kadın vaka grubunda kontrole göre önemli düzeyde yüksek bulundu. Vaka grubunda 1qh+, 9qh-, inv(9), 13ps+, 14ps+, 15ps+, 16qh+, 21ps+ ve 22ps+ polimorfizmlerinin dağılımlarında cinsiyetle ilişkili bir farklılık belirlenmedi. İnfertil kadınlarda en sık 9qh+ (%14,04) varyantına rastlandı. Polimorfizm 9qh+ oranı, kontrol grubuna göre vaka grubunda yüksek olmasına rağmen fark anlamsız bulundu. SONUÇ: İnfertilite ve kromozom polimorfizmleri arasında olası bir ilişkinin varlığına dair bulgular elde edilmiş olmasına rağmen, bu ilişkinin daha net ortaya konabilmesi için örneklem sayısının artırılması ve geniş kapasiteli yeni teknolojilerin kullanıldığı çalışmaların yapılması gereklidir.


  • Open Access

    Correction: Relationship between expression levels of TDRD7 and CRYBB3 and development of age-related cortico-nuclear cataracts

    by Saliha Handan Yildiz, Cem Karaosmanoğlu, Rahmi Duman, Nuray Varol, Müjgan Özdemir Erdoğan, Mustafa Solak, Reşat Duman, Muhsin Elmas

  • Open Access

    Relationship between expression levels of TDRD7 and CRYBB3 and development of age-related cortico-nuclear cataracts

    by Saliha Handan Yildiz, Cem Karaosmanoğlu, Rahmi Duman, Nuray Varol, Müjgan Özdemir Erdoğan, Mustafa Solak, Reşat Duman, Muhsin Elmas

    Background: The human lens develops age-related cataracts (ARCs) because of the complicated effects of aging and stressful conditions. Under conditions involving oxidative stress, cells form stress granules (SGs). TDRD7 has been identified as an RNA granule component and an important component of SGs. TDRD7 plays a role in the post-transcriptional expression of genes, such as the crystallin gene CRYBB3. Therefore, the present study investigated TDRD7 and CRYBB3 mRNA expressions in relation to age-related cortico-nuclear cataracts. Methods: Quantitative real-time PCR was used to determine the expression levels of TDRD7 and CRYBB3 in 52 patients with ARC and 52 healthy controls. Anterior lens capsules and peripheral blood samples from patients with ARC were included in the patient group, and peripheral blood samples from healthy subjects and human lens epithelial cells (HLE-B3) were included in the control group. Gene expression levels in the different age groups were compared. Correlation analysis was used to assess the gene expression levels and age. Results: The expression of TDRD7 and CRYBB3 was significantly up-regulated (P < 0.0001) in anterior lens capsules compared to that in HLE-B3 cells. Similarly, the expression of TDRD7 (P = 0.0004) and CRYBB3 (P < 0.0001) was higher in the peripheral blood samples of patients with ARC than in those of healthy subjects. Significant upregulation (P < 0.05) was observed in the 71–81-year age group of patients. No correlation was found between gene expression levels and age. Conclusion: Significantly higher expression levels of TDRD7 and CRYBB3 in patients with ARC than in controls suggest that TDRD7 and CRYBB3 are associated with the development of age-related cortico-nuclear cataracts and the aging process under chronic stress.


  • Open Access

    Analysis of polymorphisms in recurrent pregnancy loss: Factor V Leiden G1691A, Factor II G20210A, MTHFR C677T and Factor V H1299R

    by Mujgan Ozdemir Erdogan, Munevver Nisa Can, Cem Karaosmanoglu, Saliha Handan Yildiz, Mustafa Yildiz

    The distribution of factor V Leiden G1691A, factor II G20210A, MTHFR C677T, and factor V H1299R polymorphisms known to predispose to thrombophilia in 215 cases and 40 controls admitted with indication of recurrent pregnancy loss (RPL) was investigated. Genotyping was performed by melting curve analysis using simultaneous PCR (RT-PCR). There was no difference between genotype and allele frequencies in the case and control groups in terms of the polymorphisms examined (p>0.05). In the genotype distribution of the Factor V gene G1691A polymorphism, 12.6% GA in the case group and 90.0% GG (wild) genotypes in the control group were found to be higher than the other genotypes. In the genotype distribution of the factor II gene G20210A polymorphism, the GG (wild) genotype was found to be higher in 94.5% and 97.5%, respectively, in the case group and control group than the other genotypes. In the genotype distribution of MTHFR gene C677T polymorphism, 43.7% CC (wild) in the case group and 40.0% CT genotype in the control group were found to be higher than the other genotypes. In the genotype distribution of the factor V gene A4070G polymorphism, 87.4% AA (wild) in the case group and 80% AA (wild) genotype in the control group were found to be higher than the other genotypes. However, the frequency of risk allele A for factor V Leiden G1691A (6.8% and 5%), the frequency of risk allele A for factor II gene G20210A (3% and 1.2%), MTHFR gene C677T were determined in the case and control groups. The frequency of the T allele (35.9% and 42.5%), which is the risk allele for A4070G, and the frequency of the G allele (6.5% and 16.6%), which is the risk allele for the factor V gene A4070G, were determined. When our study results were evaluated, no relationship was found between RPL and factor V Leiden G1691A, factor II G20210A, MTHFR C677T, and factor V A4070G polymorphisms.

  • Open Access

    Proteomic analysis of the anticancer effect of various extracts of endemicThermopsisturcica in human cervical cancer cells

    by Mustafa Yildiz, Hakan Terzi̇, Saliha Handan Yildiz, Nuray Varol, Müjgan Özdemi̇r Erdoğan, Murat Kasap, Nermin Akçali, Mustafa Solak

    Background/aim: Thermopsis turcica is a perennial species endemic to Turkey and different extracts of T. turcica have an antiproliferative effect on cancer cells, but there has not been any report on HeLa (human cervical cancer) cells. Materials and methods: To get a better understanding of the molecular mechanism of anticancer activity of methanolic extracts of leaves (LE) and flowers (FE) of T. turcica, we employed 2-DE-based proteomics to explore the proteins involved in anticancer activity in HeLa cells. Results: T. turcica extracts showed a potent cytotoxic effect on HeLa cells with the IC50 values of 1.75 mg/mL for LE and 3.25 mg/mL for FE. The induction of apoptosis by LE and FE was also consistent with increased expression of caspase mRNAs and DNA fragmentation. In terms of the proteomic approach, 27 differentially expressed proteins were detected and identified through MALDI-TOF/TOF mass spectrometry. These altered proteins were involved in cytoskeleton organization and movement, protein folding, proteolysis and translation, cell cycle and proliferation, signal transduction, cell redox homeostasis, and metabolism. Conclusion: Up-regulation of protein disulfide isomerases and down-regulation of Rho GDP-dissociation inhibitor, heterogeneous nuclear ribonucleoproteins, and heat shock proteins may contribute to the induction of apoptosis and arresting of the cell cycle in HeLa cells.